Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06846047 · ClinicalTrials.gov registry record · NA
Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait
A NA study of Vestibulopathy, sponsored by Neursantys.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 4
- Study locations
NCT06846047 is a NA study of Vestibulopathy that is actively recruiting participants, run by Neursantys. The registered enrollment target is 500 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT06846047, a NA study of Vestibulopathy, is actively recruiting participants, sponsored by Neursantys.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The aim of the study to is determine the safety, feasibility, efficacy, and persistence of non-invasive EVS to improve balance and gait performance in healthy individuals across the lifespan. Specifically, our objective is to measure balance and gait performance before, during and after exposure to single sessions and across repeated sequences of EVS at multiple study partner sites.
Conditions Studied
Interventions
- DEVICE Sham Comparator
- DEVICE electrical vestibular stimulation (EVS)
Study Locations (4)
California
- Caring Hands Caregivers - Cupertino
- Neursantys - Menlo Park
Alberta
- University of Calgary - Calgary
New Brunswick
- Sparx Wellness Institute - Dieppe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06846047
The ClinicalTrials.gov registry entry for NCT06846047 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neursantys, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vestibulopathy appearing as the primary indexed condition, and to 2 interventions - of which Sham Comparator is the first listed.
NCT06846047 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Alberta, New Brunswick.
Frequently Asked Questions
What is clinical trial NCT06846047 about?
NCT06846047 is a clinical study titled "Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait". The aim of the study to is determine the safety, feasibility, efficacy, and persistence of non-invasive EVS to improve balance and gait performance in healthy individuals across the lifespan. Specifically, our objective is to measure balance and gait performance before, during and after exposure to ...
What is the current status of trial NCT06846047?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-01-20. Estimated completion is 2027-02-28.
What conditions does trial NCT06846047 study?
This clinical trial studies the following conditions: Vestibulopathy.
What interventions are being tested in trial NCT06846047?
The interventions under investigation include: Sham Comparator (DEVICE), electrical vestibular stimulation (EVS) (DEVICE).
Who is sponsoring clinical trial NCT06846047?
This trial is sponsored by Neursantys, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06846047 being conducted?
This trial has 4 study locations across California, Alberta, New Brunswick. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.